Sunday, October 24, 2021
Home Tags Molnupiravir

Tag: Molnupiravir

USFDA advisers to review Merck’s Molnupiravir soon

A panel of outside advisers to the US health regulator will meet late next month to discuss whether to authorise Merck &...

Merck and Ridgeback seek EUA from USFDA for Molnupiravir

Merck and Ridgeback Biotherapeutics yesterday announced that Merck has submitted an Emergency Use Authorisation (EUA) application to the US Food and Drug...

Merck asks USFDA to authorize promising Anti Covid Pill

Drugmaker Merck asked U.S. regulators Monday to authorize its pill against COVID-19 in what would add an entirely new and easy-to-use weapon to the...

Aurobindo Pharma, MSN Labs seek DCGI nod for Phase-III trials of...

Two Indian pharmaceutical companies have sought permission from India’s drug regulator to continue phase III trials on antiviral drug molnupiravir in mild C-19 patient....

Hetero seeks EU Authorisation from DCGI for Molnupiravir

HYDERABAD: The Hyderabad-based Hetero Drugs announced interim results from Phase III clinical trials of Molnupiravir in treatment of mild C-19 patients on Friday,...

These 5 Pharma giants join hands to test oral C-19 drug

HYDERABAD: The drug Molnupiravir — an antiviral oral drug which is being touted as a candidate for treatment of mild cases of C-19...

Molnupiravir: 24 घंटे में खत्म हो जाएगा C-19 का Infection: US...

Molnupiravir: 24 घंटे में खत्म हो जाएगा C-19 का Infection: US Scientists न्यूयॉर्क, IANS: C-19 वायरस के खात्मे के लिए...

Latest posts

NPPA releases draft of retail price calculation for 5 formulations

The National Pharmaceutical Pricing Authority (NPPA) has released draft version of proposed retail price calculation for five formulations, including a combination of...

Authors

51 POSTS0 COMMENTS
30 POSTS0 COMMENTS
16 POSTS0 COMMENTS
15 POSTS0 COMMENTS
11 POSTS0 COMMENTS
9 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS